asthma news and updates

In Depth 18 Jun 2025

From undruggable to oral therapy: The rise of STAT6 degraders

Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

June 18, 2025 - 5 minutesmins - By Jules Adam

In Depth 2 May 2023

The future of asthma treatment: is a cure possible?

For around 300 million people in the world, whipping out their inhaler – a medical device that delivers medicine to the lungs to open up narrowed airways – before puffing medicine into their mouth, is a typical response to wheezing, worsened by an asthma attack. While inhalers offer momentary relief, it is, however, no cure. […]

May 2, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 27 Apr 2023

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

Arrowhead Pharmaceuticals Inc. has announced interim results from an ongoing phase 1/2 clinical study of ARO-RAGE, an investigational RNA interference (RNAi) therapeutic designed to reduce production of the receptor for advanced glycation end products (RAGE) as a potential treatment for inflammatory pulmonary diseases, such as asthma. These data represent the first clinical demonstration of the […]

April 27, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 11 Jan 2023

AstraZeneca’s Airsupra gets US approval as new rescue treatment for asthma

Avillion LLP says the US Food and Drug Administration (FDA) has approved AstraZeneca’s Airsupra for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older. Airsupra, (albuterol/budesonide, formerly known as PT027) is a first-in-class, pressurized metered-dose inhaler (pMDI), fixed-dose combination rescue medication […]

January 11, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 5 Sep 2022

Sanofi and Regeneron’s Dupixent shows sustained improvement in lung function in children

A maintenance therapy from Sanofi and Regeneron, added to other asthma medications, has shown sustained improvement in lung function, low-rate of asthma attacks and a consistent safety profile for up to two years in children. Results from the longest global phase 3 open-label extension trial in the age group six to 11 years old with […]

September 5, 2022 - 3 minutesmins - By Liza Laws

News and Trends 9 Aug 2022

Asthma in the spotlight as Upstream Bio starts trial and UK universities propose new long-term treatment

Upstream Bio, a clinical-stage biotech company advancing new therapies to treat inflammation, has initiated a phase 1b multiple ascending dose study of UPB-101 in asthma patients with the dosing of the first patient. Meanwhile, a possible way to tackle one of the underlying causes of asthma has been developed by researchers from Aston University and […]

August 9, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 22 Jun 2022

From mugwort allergy to an effective vaccine?

A research team at MedUni Vienna in Austria says it has discovered key mechanisms of allergy to pollen from the common weed mugwort, which could lay the foundation for the development of the world’s first vaccine. Mugwort (Artemisia vulgaris) poses a serious problem for some people with allergies in places where the plant is common […]

June 22, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 2 Jun 2022

Upstream Bio to target asthma as it launches with $200M financing

Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M Series A financing. The company said the funding will allow it to advance its lead program UPB-101, a clinical-stage monoclonal antibody targeting the thymic stromal lymphopoietin (TSLP) receptor. It added the investment will also help build a pipeline of assets […]

June 2, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

asthma

From undruggable to oral therapy: The rise of STAT6 degraders

The future of asthma treatment: is a cure possible?

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

AstraZeneca’s Airsupra gets US approval as new rescue treatment for asthma

Sanofi and Regeneron’s Dupixent shows sustained improvement in lung function in children

Asthma in the spotlight as Upstream Bio starts trial and UK universities propose new long-term treatment

From mugwort allergy to an effective vaccine?

Upstream Bio to target asthma as it launches with $200M financing

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!